Medicament for treating hyperosteogeny

A technology of bone hyperplasia and bone-penetrating grass, which can be used in bone diseases, drug combinations, pharmaceutical formulas, etc., can solve the problem of no formula, and achieve obvious curative effects.

Inactive Publication Date: 2010-01-06
吴江维
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] There is no formula close to the present invention in the medicine for the treatment of hyperosteogeny on the market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0007] A medicine for treating hyperosteogeny, comprising 10% of Artemisia annua (made), 10% of Buliuxing, 10% of Scutellaria saponica, 10% of Rhizoma chinensis, 10% of Nuxychia (manufactured), 10% by weight percentage, 10% of blowing powder, 10% of earth-boring wind, 10% of triangular maple (manufactured), 10% of star anise maple (manufactured), and 10% of Sperantosporum are ground into powder.

[0008] When in use, mix with boiled water and apply to the affected area, then bandage it.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicament for treating hyperosteogeny, which is prepared by grinding the following materials into powder in percentage by weight: 8 to 15 percent of alpine yallow herb (prepared), 7 to 14 percent of seed of cowherb, 8 to 14 percent of brook anemone, 7 to 15 percent of ranunculus sceleratus, 8 to 14 percent of nux vomica (prepared), 7 to 13 percent of oblongleaf kadsura stem or root, 6 to 13 percent of Chinese hydrangeavine root-bark, 8 to 13 percent of trident maple (prepared), 7 to 16 percent of Chinese alangium (prepared), and 7 to 15 percent of caulis impatientis. The medicament is for external use, has obvious curative effects of treating the hyperosteogeny, unknown sores or boils, post injury bone ache and various arthralgia, and is mixed with boiled water in use and is applied to an affected part which is then bandaged.

Description

Technical field: [0001] A medicine for treating hyperosteogeny belongs to medicines. Background technique: [0002] There is no formula close to the present invention in the medicine for treating hyperosteogeny on the market at present. Invention content: [0003] The purpose of the present invention is to invent a medicine which has obvious curative effect on the treatment of hyperosteogeny, nameless swelling, post-injury bone pain and various joint pains. [0004] A kind of medicine for treating hyperosteogeny, which consists of Artemisia chinensis (made), Wangbuliuxing, tiger's palm grass, Shilongrui, Nuxynum (made), Fengfengsan, ground-drilling wind, triangular maple (made), star anise Maple (produced) and Sperantosporum are ground into powder, by weight percentage, Artemisia argyi (produced) 8%-15%, Vaccaria 7%-14%, Sagittarius 8%-14%, Shilong Rui 7%-15%, Nuxychia (manufactured) 8%-14%, Fengfengsan 7%-13%, Earth-boring wind 6%-13%, Triangle maple (manufactured) 8%-1...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/87A61K36/85A61P19/10
Inventor 吴江维
Owner 吴江维
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap